Stemline amends IPO

Stemline Therapeutics Inc., New York, N.Y. Business: Cancer Date announced: 1/8/13 Type: IPO To be raised: Up to $32.6 million Shares: 2.3 million Price: $10-$12 Underwriters: Aegis Capital; Feltl; Su...